Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-08 4:31 pm Sale | 2023-11-30 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 12,303,701 4.200% | -5,281,315 (-30.03%) | Filing History |
| 2023-02-14 4:16 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 28,599,494 9.900% | 194,452 (+0.68%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,642,917 9.800% | 286,874 (+1.05%) | Filing History |
| 2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 26,800,000 9.500% | 8,300,000 (+44.86%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 26,538,371 9.450% | 893,187 (+3.48%) | Filing History |
| 2023-02-08 12:42 pm Purchase | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 17,585,016 6.300% | 4,847,359 (+38.06%) | Filing History |
| 2023-02-06 2:49 pm Sale | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 8,107,347 2.890% | -18,541,327 (-69.58%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 20,133,992 7.200% | 323,644 (+1.63%) | Filing History |
| 2023-01-05 11:11 am Sale | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 13,461,924 4.700% | -1,876,753 (-12.24%) | Filing History |
| 2022-03-02 4:16 pm Sale | 2022-02-23 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,356,043 9.700% | -400 (-0.00%) | Filing History |
| 2022-03-02 3:38 pm Purchase | 2022-02-23 | 13D | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,356,443 9.700% | 797,000 (+3.00%) | Filing History |
| 2022-02-22 5:19 pm Unchanged | 2021-07-02 | 13D | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 28,405,042 9.990% | 6,279,553 (+28.38%) | Filing History |
| 2022-02-14 3:45 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% | 1,447,395 (+5.76%) | Filing History |
| 2022-02-11 10:05 am Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 18,500,000 6.600% | 7,300,000 (+65.18%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 25,645,184 9.200% | 1,799,751 (+7.55%) | Filing History |
| 2022-02-04 09:15 am Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 26,648,674 9.560% | 26,648,674 (New Position) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 19,810,348 7.100% | -2,067,094 (-9.45%) | Filing History |
| 2022-01-19 12:37 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 15,338,677 5.500% | 15,338,677 (New Position) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 22,125,489 8.500% | -3,357,280 (-13.17%) | Filing History |